Integrated BioPharma announces National Science Foundation award. (Industry News).
The National Science Foundation has awarded funding for a Small
Business Innovative Research proposal titled, "Regulated Expression
of Therapeutic Proteins in Transgenic Brassica Plants" to
Integrated BioPharma, Hillside, NJ. The proposal was prepared and
submitted by NuCycle Therapy, a wholly owned subsidiary of Integrated
BioPharma. The scientists plan to introduce the gene encoding human
alpha interferon into Brassica, an edible crop plant, using a novel and
proprietary gene transfer method. The GMO plants can then be grown in an
environmentally safe way and used as an inexpensive source of human
alpha interferon. Interferon is used to treat diseases such as chronic
hepatitis and AIDS-related diseases, and a less expensive source of this
drug has worldwide health benefits.